Sophiris Bio (SPHS) Return on Assets ROA from the third quarter of 2019 to third quarter of 2018 and for the year 2019, Average High and Low, Fundamental Ratios from Sep 30 2019 to Sep 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sophiris Bio Inc.  (SPHS)


Sophiris Bio's ROA from the third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Sophiris Bio's ROA in the third quarter of 2019?
Sophiris Bio Inc. achieved a return on average assets (ROA) of 0.41 % in its third quarter of 2019, this is above SPHS's average return on assets of -47.96%.
Sophiris Bio Inc. assets over the 12 months ending in its third quarter of 2019 are valued at $9 million

ROA has improved compared to -16.83% in the second quarter of 2019, due to net income growth.

However, within the Healthcare sector 196 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2019 quarter, so far to 2693, from total ROA ranking in the second quarter of 2019 at 3797.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Total Assets Change -54.57 % -67.71 % -58.38 % -50.89 % -48.01 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 0 -2 -6 -7 -16
Return On Assets (TTM) 0.41 % -16.83 % -40.18 % -38.01 % -76.53 %
SPHS's Total Ranking # 2693 # 3797 # 4259 # 4669 # 4515
Total Assets (TTM) in million 7 6 10 13 15
Seq. Total Assets Change 10.89 % -34.2 % -27.18 % -14.5 % -21.18 %
Seq. Net Income Change - - - - -

SPHS's 5 Years Annual ROA >> Back to SPHS Management Effectiveness >> Compare SPHS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 67
Sector # 197
Overall # 2605

Return On Assets Statistics
High Average Low
74.44 %
-47.96 %
-144 %
(Mar 31 2014)   (Jun 30 2016)





Financial Statements
Sophiris Bio's Assets $ 7 million SPHS's Balance sheet
Sophiris Bio's Income $ -1 million Quarterly SPHS's Income Statement
SPHS's Income by Division See SPHS's Income by Division



Annual Return On Assets (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015		 (Dec 31 2014)
FY 2014
Y / Y Total Assets Change -50.89 % -10.4 % 237.36 % -65.25 % -50.68 %
Total Assets in million 13 27 30 9 26
Y / Y Net Income Change - - - - -
Net Income in million -7 -9 -11 -14 -31
Annual Return On Assets -51.35 % -32.1 % -37.22 % -159.66 % -120.01 %

SPHS's 5 Years Annual ROA >> Back to SPHS Management Effectiveness >> Compare SPHS ROA to its Competitors



More Return On Assets Ratios
SPHS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SPHS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SPHS's Competitors
Subscribers only: Roa for Sophiris Bio's Suppliers
Subscribers only: Return On Assets for SPHS's Customers

You may also want to know
SPHS's Roi SPHS's Inventory Turnover Ratio SPHS's Growth Rates SPHS's Dividend Comparisons
SPHS's Profitability Ratios SPHS's Asset Turnover Ratio SPHS's Dividend Growth
SPHS's Roe SPHS's Valuation Ratios SPHS's Financial Strength Ratios SPHS's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2019, within Healthcare Sector ROA
Merit Medical Systems Inc  1.11 %
Elanco Animal Health Incorporated  1.06 %
Luminex Corporation  1.06 %
Procyon Corporation  0.96 %
Envista Holdings Corporation  0.95 %
Enzo Biochem Inc  0.76 %
Tenet Healthcare Corp  0.65 %
Natus Medical Inc  0.60 %
National Vision Holdings Inc   0.53 %
Scienture Holdings Inc   0.53 %
American Renal Associates Holdings Inc   0.47 %
Sophiris Bio Inc.  0.41 %
Infusystem Holdings Inc  0.40 %
Pacira Biosciences inc   0.29 %
Lannett Company Inc  0.27 %
Magellan Health inc   0.24 %
Jrsis Health Care Corp  0.22 %
Emergent Biosolutions Inc   0.19 %
Lakeland Industries Inc   0.15 %
Mylan N v   0.15 %

Date modified: 2026-09-08T15:09:43+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.